17 results
FWP
KPRX
Kiora Pharmaceuticals Inc
15 May 23
Free writing prospectus
5:18pm
- AEs, PK & labs ▪ Secondary - Assessment days (shown only for Cohort 1 above) is repeated for each cohort per eye; intensity & contrast assessment … Intensity & Contrast Light Perception Goldmann Perimetry Visual Field MLOM Suite of ‘functional’ tests fMRI Cortical Imaging Subjective Interviews
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
11 Jan 22
Regulation FD Disclosure
12:00am
Light Intensity (photons/cm 2 · sec) KIO - 301: Light Intensity and Wavelength Sci. Rep. 7, 45487 (2017), Banghart, Trauner et al (2008) Wavelength (nm
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
14 Sep 21
Regulation FD Disclosure
4:20pm
Retinas Normal Retina Diseased Retina
26 10 13 10 14 10 15 10 16 10 17 0.0 0.2 0.4 0.6 Light Intensity (photons/cm 2sec) L i g h t R e s p o n s e I … n d e x Moonlight 100w Incandescent Light Bulb Cloudy Day Sunlight Light Intensity (photons/cm 2 · sec) B - 203: How Much and Which Wavelengths
FWP
KPRX
Kiora Pharmaceuticals Inc
14 Jul 22
Free writing prospectus
5:14pm
Intensity (photons/cm 2 · sec) KIO - 301: Restore Vision in Daily - Life Regular Settings Molecule Sensitive to a Broad Spectrum of Intensity
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Regulation FD Disclosure
7:02am
) is repeated for each cohort per eye; intensity & contrast assessment, kine8c perimetry, func8onal MRI, etc. § Safety review conducted … ), 1257-1264 Cohort 2 (3 patients, 3 eyes)
17 Light Perception (Intensity & Contrast Assessment) Assessment: § Series of visual s8muli (a series
8-K
EX-99.1
x50g8y9m0il0reup3
12 Feb 24
Regulation FD Disclosure
5:23pm
10-K
c8w710n3te
31 Mar 15
Annual report
12:00am
DRS/A
qk5lfakq1tc76qwywoc
8 Jul 14
Draft registration statement (amended)
12:00am
424B4
oi7qlckootdzar0m
13 Feb 15
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next